Department of Pharmaceutical Sciences, University of Perugia, Perugia 06122, Italy.
Taverne di Corciano, TES Pharma, Perugia 06073, Italy.
J Med Chem. 2020 Apr 9;63(7):3701-3712. doi: 10.1021/acs.jmedchem.0c00012. Epub 2020 Mar 20.
Pregnane X receptor (PXR) is a master xenobiotic-sensing transcription factor and a validated target for immune and inflammatory diseases. The identification of chemical probes to investigate the therapeutic relevance of the receptor is still highly desired. In fact, currently available PXR ligands are not highly selective and can exhibit toxicity and/or potential off-target effects. In this study, we have identified garcinoic acid as a selective and efficient PXR agonist. The properties of this natural molecule as a specific PXR agonist were demonstrated by the screening on a panel of nuclear receptors, the assessment of the physical and thermodynamic binding affinity, and the determination of the PXR-garcinoic acid complex crystal structure. Cytotoxicity, transcriptional, and functional properties were investigated in human liver cells, and compound activity and target engagement were confirmed in vivo in mouse liver and gut tissue. In conclusion, garcinoic acid is a selective natural agonist of PXR and a promising lead compound toward the development of new PXR-regulating modulators.
孕烷 X 受体 (PXR) 是一种主要的外源性物质感知转录因子,也是免疫和炎症性疾病的一个已验证的靶点。因此,人们仍然非常需要寻找化学探针来研究该受体的治疗相关性。事实上,目前可用的 PXR 配体选择性不高,可能具有毒性和/或潜在的脱靶效应。在这项研究中,我们发现了 Garcinoic 酸是一种选择性和有效的 PXR 激动剂。该天然分子作为特定 PXR 激动剂的特性通过对一组核受体进行筛选、评估物理和热力学结合亲和力以及确定 PXR-Garcinoic 酸复合物晶体结构得到了证明。在人肝细胞中研究了细胞毒性、转录和功能特性,并在小鼠肝和肠道组织中体内证实了化合物的活性和靶标结合。总之,Garcinoic 酸是 PXR 的选择性天然激动剂,是开发新型 PXR 调节调节剂的有前途的先导化合物。